Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.


TSXV:XRTX - Post by User

Post by SpaceLabson Nov 25, 2021 2:03pm
319 Views
Post# 34165959

XRX Shr Holdrs are in DEEP DOO DOO! after NasDaq Listing by

XRX Shr Holdrs are in DEEP DOO DOO! after NasDaq Listing by NNB, i.e a NO NAME BRAND Fund Managers from the RoadRunner Financiers in NY, BOSTON and CALGARY.
They have NOT been able to garner INSTITUTIONAL INVESTORS Interests to date, it is these R'Runner who have DELIBERATELY TANKED Xortx after the Listing on a VERY PROMINENT Exchange called NASDAQ, 
REASON for TANKING:
They are showing Allen CEO that they did XRX a HUGE Favor in IPO at US$4/shr while the shrprc today is only C$3/shr.
BRAINWASH Dr. CEO but not the GRASSROOTS of XRX.

Dr. CEO of XRX has to Wake Up to shareholders concerns and NEVER in FUTURE engage a No Name Fund Managers to raise CAPITAL.

A mere US$12 Million is PEANUTS in any IPO on NASDAQ my friend AB42 & Boiler Operative AK so don't post your BLATANT LIES on BB pls.
<< Previous
Bullboard Posts
Next >>